191 related articles for article (PubMed ID: 31567587)
1. How Wide Should the Excision Margins for Facial Small Aggressive Basal Cell Carcinoma Be? Experience With 306 Cases.
Ariza SA; Calderón DC; Aristizábal JC; Parra-Medina R
Dermatol Surg; 2020 Jun; 46(6):753-756. PubMed ID: 31567587
[TBL] [Abstract][Full Text] [Related]
2. Surgical margins required for basal cell carcinomas treated with Mohs micrographic surgery according to tumor features.
Cerci FB; Kubo EM; Werner B; Tolkachjov SN
J Am Acad Dermatol; 2020 Aug; 83(2):493-500. PubMed ID: 32289390
[TBL] [Abstract][Full Text] [Related]
3. Tissue-sparing properties of Mohs micrographic surgery for infiltrative basal cell carcinoma.
van Kester MS; Goeman JJ; Genders RE
J Am Acad Dermatol; 2019 Jun; 80(6):1700-1703. PubMed ID: 30710602
[TBL] [Abstract][Full Text] [Related]
4. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
Blixt E; Nelsen D; Stratman E
Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
[TBL] [Abstract][Full Text] [Related]
5. Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study.
Sin CW; Barua A; Cook A
Int J Dermatol; 2016 Sep; 55(9):1044-7. PubMed ID: 27152747
[TBL] [Abstract][Full Text] [Related]
6. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
7. Basal cell carcinoma treated with Mohs micrographic surgery in young Ibero-American patients.
Aluma-Tenorio MS; Ávila-Álvarez A; Jaimes N; Caballero-Uribe N; González A; Terzian LR; Ocampo-Candiani J; Zuluaga MA; Garza-Rodríguez V; Tamayo-Betancur MC; Cuesta-Castro DP; Garcés JR; Ruiz-Salas V; Goldberg L; Kimyai-Asadi A
Int J Dermatol; 2018 Dec; 57(12):1447-1453. PubMed ID: 30168850
[TBL] [Abstract][Full Text] [Related]
8. Prediction of the invasive level of basal cell carcinomas in the facial area: Analysis of 718 Japanese cases.
Matsushita S; Nakamura Y; Tanaka R; Araki R; Yamamura K; Yoshioka M; Inoue A; Komori T; Saito S; Teramoto Y; Nakamura Y; Fujisawa Y; Aoki M
J Dermatol Sci; 2020 Sep; 99(3):152-157. PubMed ID: 32811698
[TBL] [Abstract][Full Text] [Related]
9. Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study.
Lim GF; Perez OA; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2022 Jun; 86(6):1309-1317. PubMed ID: 35231546
[TBL] [Abstract][Full Text] [Related]
10. Non-Melanoma Skin Cancer Tumor's Characteristics and Histologic Subtype as a Predictor for Subclinical Spread and Number of Mohs Stages required to Achieve Tumor-Free Margins.
Santos-Arroyo A; Carrasquillo OY; Cardona R; Sánchez JL; Valentín-Nogueras S
P R Health Sci J; 2019 Mar; 38(1):40-45. PubMed ID: 30924914
[TBL] [Abstract][Full Text] [Related]
11. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.
Mosterd K; Krekels GA; Nieman FH; Ostertag JU; Essers BA; Dirksen CD; Steijlen PM; Vermeulen A; Neumann H; Kelleners-Smeets NW
Lancet Oncol; 2008 Dec; 9(12):1149-56. PubMed ID: 19010733
[TBL] [Abstract][Full Text] [Related]
12. [Complete treatment of basal cell carcinoma; cost effectiveness of Mohs micrographic surgery versus conventional excision].
Muche JM; van Rengen A; Mosterd K
Ned Tijdschr Geneeskd; 2017; 161():D1549. PubMed ID: 29303086
[TBL] [Abstract][Full Text] [Related]
13. 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma.
Paoli J; Daryoni S; Wennberg AM; Mölne L; Gillstedt M; Miocic M; Stenquist B
Acta Derm Venereol; 2011 Oct; 91(6):689-93. PubMed ID: 21681360
[TBL] [Abstract][Full Text] [Related]
14. [Mohs micrographic surgery for repeat excision of basal cell carcinomas on the head with positive margins].
Angulo J; Serra-Guillén C; Traves V; Botella-Estrada R; Sanmartín O; Llombart B; Requena C; Guillén C; Nagore E
Actas Dermosifiliogr; 2011 Dec; 102(10):797-804. PubMed ID: 21684507
[TBL] [Abstract][Full Text] [Related]
15. Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread.
Hoorens I; Batteauw A; Van Maele G; Lapiere K; Boone B; Ongenae K
Br J Dermatol; 2016 Apr; 174(4):847-52. PubMed ID: 26595159
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas.
Kimyai-Asadi A; Alam M; Goldberg LH; Peterson SR; Silapunt S; Jih MH
J Am Acad Dermatol; 2005 Sep; 53(3):464-8. PubMed ID: 16112354
[TBL] [Abstract][Full Text] [Related]
17. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
[TBL] [Abstract][Full Text] [Related]
18. Management of periocular basal and squamous cell carcinoma: a series of 485 cases.
Nemet AY; Deckel Y; Martin PA; Kourt G; Chilov M; Sharma V; Benger R
Am J Ophthalmol; 2006 Aug; 142(2):293-7. PubMed ID: 16876511
[TBL] [Abstract][Full Text] [Related]
19. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological factors influencing the number of stages of Mohs surgery for basal cell carcinoma.
Calvão J; Pinho A; Brinca A; Vieira R
An Bras Dermatol; 2022; 97(3):291-297. PubMed ID: 35379511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]